{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Mometasone+nasal+spray&page=2", "query": { "intervention": "Mometasone nasal spray", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 36, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Mometasone+nasal+spray&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Mometasone+nasal+spray&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-10T07:04:39.292Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06013241", "title": "A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Rhinosinusitis Without Nasal Polyps" ], "interventions": [ { "name": "Brensocatib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Mometasone furoate nasal spray (MFNS)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Insmed Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 288, "start_date": "2023-10-30", "completion_date": "2025-10-30", "has_results": false, "last_update_posted_date": "2026-09-30", "last_synced_at": "2026-10-10T07:04:39.292Z", "location_count": 27, "location_summary": "Tucson, Arizona • Roseville, California • Upland, California + 21 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Roseville", "state": "California" }, { "city": "Upland", "state": "California" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Hollywood", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06013241" }, { "nct_id": "NCT02291549", "title": "S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Nasal Polyps", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Sinusitis", "Nasal Polyposis" ], "interventions": [ { "name": "S8 Sinus Implant", "type": "DRUG" }, { "name": "Mometasone furoate nasal spray", "type": "DRUG" }, { "name": "Sham", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Intersect ENT", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2014-12", "completion_date": "2016-10", "has_results": true, "last_update_posted_date": "2018-08-15", "last_synced_at": "2026-10-10T07:04:39.292Z", "location_count": 40, "location_summary": "Birmingham, Alabama • Irvine, California • Sacramento, California + 33 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Irvine", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT02291549" }, { "nct_id": "NCT03280550", "title": "A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Nasal Polyps", "Chronic Rhinosinusitis" ], "interventions": [ { "name": "Omalizumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 138, "start_date": "2017-11-15", "completion_date": "2019-03-11", "has_results": true, "last_update_posted_date": "2020-03-23", "last_synced_at": "2026-10-10T07:04:39.292Z", "location_count": 11, "location_summary": "Los Angeles, California • Roseville, California • Miami, Florida + 8 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Roseville", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Twin Falls", "state": "Idaho" }, { "city": "Marrero", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT03280550" }, { "nct_id": "NCT03614923", "title": "Etokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Rhinosinusitis" ], "interventions": [ { "name": "Etokimab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "Mometasone Furoate Nasal Spray", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "AnaptysBio, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 105, "start_date": "2018-11-29", "completion_date": "2020-10-26", "has_results": true, "last_update_posted_date": "2022-01-24", "last_synced_at": "2026-10-10T07:04:39.292Z", "location_count": 28, "location_summary": "Little Rock, Arkansas • Canoga Park, California • Roseville, California + 24 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Canoga Park", "state": "California" }, { "city": "Roseville", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03614923" }, { "nct_id": "NCT01673659", "title": "A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 50 mcg/Actuation in the Relief of the Symptoms of Seasonal Allergic Rhinitis (SAR)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Seasonal Allergic Rhinitis" ], "interventions": [ { "name": "Mometasone furoate", "type": "DRUG" }, { "name": "Nasonex Nasal Spray", "type": "DRUG" }, { "name": "Placebo nasal spray", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Padagis LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "12 Years to 65 Years" }, "enrollment_count": 1220, "start_date": "2012-08", "completion_date": "2012-10", "has_results": false, "last_update_posted_date": "2021-10-22", "last_synced_at": "2026-10-10T07:04:39.292Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01673659" }, { "nct_id": "NCT03280537", "title": "A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Nasal Polyps", "Chronic Rhinosinusitis" ], "interventions": [ { "name": "Omalizumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 127, "start_date": "2017-11-21", "completion_date": "2019-03-07", "has_results": true, "last_update_posted_date": "2020-03-23", "last_synced_at": "2026-10-10T07:04:39.292Z", "location_count": 16, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Rancho Cordova, California + 13 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Rancho Cordova", "state": "California" }, { "city": "Stockton", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03280537" }, { "nct_id": "NCT06834347", "title": "A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Rhinosinusitis With Nasal Polyps" ], "interventions": [ { "name": "Itepekimab (SAR440340)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Mometasone furoate nasal spray (MFNS)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 231, "start_date": "2025-02-12", "completion_date": "2027-09-16", "has_results": false, "last_update_posted_date": "2026-05-20", "last_synced_at": "2026-10-10T07:04:39.292Z", "location_count": 21, "location_summary": "Arcadia, California • Los Angeles, California • Newport Beach, California + 16 more", "locations": [ { "city": "Arcadia", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Roseville", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06834347" }, { "nct_id": "NCT01287364", "title": "Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Perennial Allergic Rhinitis" ], "interventions": [ { "name": "ciclesonide hydrofluoroalkane (HFA) nasal aerosol", "type": "DRUG" }, { "name": "mometasone nasal inhalation", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 185, "start_date": "2011-02", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2012-11-02", "last_synced_at": "2026-10-10T07:04:39.292Z", "location_count": 6, "location_summary": "Mission Viejo, California • San Diego, California • North Dartmouth, Massachusetts + 3 more", "locations": [ { "city": "Mission Viejo", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "Minneappolis", "state": "Minnesota" }, { "city": "Skillman", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01287364" }, { "nct_id": "NCT00720382", "title": "A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Perennial Allergic Rhinitis" ], "interventions": [ { "name": "0.15% azelastine hydrochloride", "type": "DRUG" }, { "name": "Mometasone furoate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Meda Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 703, "start_date": "2007-03", "completion_date": "2008-07", "has_results": true, "last_update_posted_date": "2015-05-21", "last_synced_at": "2026-10-10T07:04:39.292Z", "location_count": 59, "location_summary": "Oxford, Alabama • Fountain Valley, California • Huntington Beach, California + 50 more", "locations": [ { "city": "Oxford", "state": "Alabama" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00720382" }, { "nct_id": "NCT03401229", "title": "Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Nasal Polyposis" ], "interventions": [ { "name": "Benralizumab 30 mg SC + Mometasone Furoate", "type": "BIOLOGICAL" }, { "name": "Matching placebo SC + Mometasone Furoate", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 413, "start_date": "2018-01-15", "completion_date": "2020-07-31", "has_results": true, "last_update_posted_date": "2021-10-12", "last_synced_at": "2026-10-10T07:04:39.292Z", "location_count": 48, "location_summary": "Birmingham, Alabama • Fresno, California • Huntington Beach, California + 37 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fresno", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03401229" } ] }